Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AERAS-402 in HIV-infected, BCG-vaccinated Adults
NCT01017536Phase 2Completed
- Sponsor
- Aeras Global Vaccine Foundation
- Start
- Dec 2009
- Primary completion
- Mar 2012
- Modality
- Viral Vector Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of AERAS-402 in Tuberculosis (TB), sponsored by Aeras Global Vaccine Foundation. Started Dec 2009; status: completed.
02
Drugs
AERAS-402
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT01017536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017536.